Core Insights - Datatrak International has secured a $6,600,000 contract for its eTMF, ePRO/eCOA, and eConsent solutions, aimed at enhancing clinical trial documentation and processes [2][3] - The Datatrak eClinical Technology Platform is highlighted as the only true eSource solution that integrates various clinical trial management functions into a single user-friendly dashboard [1][4] Company Update - The contract will enable the integration of Datatrak's eTMF, ePRO/eCOA, and eConsent with EDC, RTSM, and CTMS, driving efficiency and improving visibility across data management needs for clinical trials [2][3] - Datatrak's platform is designed to be flexible and customizable, allowing it to meet diverse protocol requirements while providing total control over data, documents, workflows, and permissions [3][4] Technology and Compliance - The eClinical system is compliant with high-quality assurance standards, including Part 11, HIPAA, and GDPR, which enhances overall operational efficiency [3][6] - Datatrak's technology aims to reduce costs associated with medical device and drug development by offering competitively priced solutions compared to other eClinical vendors [3][6] Market Position - Datatrak has over 30 years of experience in the life sciences industry, being a pioneer in EDC and cloud software, and is trusted in 83 countries with over 10,000 clinical trials conducted [6]